CytoArm CO., LTD.
Update：2023/06/12
Industries
Main Industry
Health Care
Main Product/Service
CytoArm’s flagship technology is its Armed-T™ cell therapy, which uses a non-viral manufacturing process to produce tumor-specific T cells with over 90% purity in around 10 days. The platform is highly adaptable, with the potential to develop treatments f
Founded Year
2020
Unified Business No.
83469938
Status
Active
Number of Employees
0
Total Paid-in
Capital
36,700,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
CytoArm Co., Ltd. is a Taiwan-based biotech company focused on next-generation T cell therapies. Leveraging its proprietary Armed-T™ platform, CytoArm equips T cells with bi-functional antibodies (BsAb) to enable precise tumor targeting, all without using
